ISSN:

Journal Home

Advances in Rheumatology Q2 Unclaimed

BioMed Central Ltd United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Advances in Rheumatology is a journal indexed in SJR in Rheumatology with an H index of 38. It is an CC BY Journal with a Double blind peer review review system The scope of the journal is focused on rheumatology, rheumatic diseases. It has an SJR impact factor of 0,704 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,704.

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Rheumatology (Q2)

Price

0 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,704

SJR Impact factor

38

H Index

56

Total Docs (Last Year)

167

Total Docs (3 years)

2228

Total Refs

403

Total Cites (3 years)

160

Citable Docs (3 years)

2.07

Cites/Doc (2 years)

39.79

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Rheumatic Disease Clinics of North America Q2
Rheumatology International Q2
Autoimmunity Highlights Q2
Clinical and Experimental Rheumatology Q2
Clinical Rheumatology Q2

Compare this journals

Aims and Scope

Rheumatology Rheumatic diseases